Comparative Study
[The protective action of arbidol during a rise in respiratory diseases in 1990]
[Article in
Russian]
- PMID: 1666474
Item in Clipboard
Comparative Study
[The protective action of arbidol during a rise in respiratory diseases in 1990]
[Article in
Russian]
Vopr Virusol.
1991 Sep-Oct.
Abstract
Prophylactic properties of a new chemical drug, arbidol, against acute respiratory diseases (ARD) were studied. Arbidol given daily in a dose of 0.2 g for 19 days reduced the morbidity rate 2.3-fold in adults during an outbreak of ARD. Geometric mean titres of antibodies to respiratory viruses among healthy persons did not change after treatment with arbidol indicating the lack of immunosuppressive properties in the drug. The prophylactic effect of arbidol may be due to both specific effect of the drug on influenza and parainfluenza viruses, and its interferon-inducing and immunity-stimulating properties.
Similar articles
-
Viral and rickettsial etiology of an outbreak of acute respiratory tract infection.Virologie. 1985 Jul-Sep;36(3):195-200. Virologie. 1985. PMID: 4071978
-
[Protective action of remantadine during an influenza outbreak caused by virus A (H1N1) in December 1977].Vopr Virusol. 1979 Jul-Aug;(4):353-7. Vopr Virusol. 1979. PMID: 483772 Russian.
-
Upper respiratory tract infection and serum antibody responses in nursing home patients.Am J Infect Control. 1988 Aug;16(4):152-8. doi: 10.1016/0196-6553(88)90026-0. Am J Infect Control. 1988. PMID: 2847597 Free PMC article.
-
First International Symposium on Influenza and Other Respiratory Viruses: summary and overview: Kapalua, Maui, Hawaii, December 4-6, 1998.Antiviral Res. 1999 Jul;42(3):149-75. doi: 10.1016/s0166-3542(99)00034-0. Antiviral Res. 1999. PMID: 10443529 Free PMC article. Review. No abstract available.
-
[The treatment of influenza and acute respiratory viral infections].Lik Sprava. 2013 Mar;(2):99-106. Lik Sprava. 2013. PMID: 24605619 Review. Russian.
Cited by
-
Current Strategies for Inhibition of Chikungunya Infection.Viruses. 2018 May 3;10(5):235. doi: 10.3390/v10050235. Viruses. 2018. PMID: 29751486 Free PMC article. Review.
-
Modeling the Structure-Activity Relationship of Arbidol Derivatives and Other SARS-CoV-2 Fusion Inhibitors Targeting the S2 Segment of the Spike Protein.J Chem Inf Model. 2021 Dec 27;61(12):5906-5922. doi: 10.1021/acs.jcim.1c01061. Epub 2021 Dec 13. J Chem Inf Model. 2021. PMID: 34898207 Free PMC article.
-
Arbidol as a broad-spectrum antiviral: an update.Antiviral Res. 2014 Jul;107:84-94. doi: 10.1016/j.antiviral.2014.04.006. Epub 2014 Apr 24. Antiviral Res. 2014. PMID: 24769245 Free PMC article. Review.